P
LMAT icon

&Partners’s LeMaitre Vascular LMAT Stock Holding History

&Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Sell
2,440
-176
-7% -$18K ﹤0.01% 2289
2026
Q1 		$286K Sell
2,616
-217
-8% -$20.7K ﹤0.01% 2033
2025
Q4 		$230K Buy
2,833
+44
+2% +$3.79K ﹤0.01% 2069
2025
Q3 		$244K Buy
+2,789
New +$249K ﹤0.01% 1851

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

&Partners's LMAT Position: Q2 2026 in Review

&Partners reduced its LeMaitre Vascular (LMAT) stake by 6.7% in Q2 2026, selling an estimated $18K and leaving 2,440 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

&Partners first reported a position in LMAT in Q3 2025 and has held it in 4 quarters since. The position peaked at $286K in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • &Partners held 2,440 shares of LeMaitre Vascular worth $234K as of Q2 2026.
  • &Partners sold 176 LeMaitre Vascular shares in Q2 2026, an estimated $18K.
  • LeMaitre Vascular made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2289 holding.
  • &Partners first reported a position in LeMaitre Vascular in Q3 2025 and has held it in 4 quarters since.
  • &Partners's LeMaitre Vascular position peaked at $286K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.